MEN 10208
MEN 10208 is a neurokinin A antagonist prepared by solid phase synthesis. The Fmoc strategy has more advantages than the Boc strategy in its preparation, and can obtain products with higher yield and purity.
Product Specifications
CAS Number
129781-07-3
UNSPSC
12352209
Target
Neurokinin Receptor
Type
Peptides
Related Pathways
GPCR/G Protein; Neuronal Signaling
Applications
Neuroscience-Neuromodulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/men-10208.html
Smiles
N=C(N)NCCC[C@@H](C(N)=O)NC([C@@H](CC1=CNC2=CC=CC=C12)NC([C@H](NC([C@H](C(C)C)NC([C@H](NC([C@@H](NC([C@H](CC(O)=O)NC([C@@H](N)[C@H](O)C)=O)=O)CC3=CC=C(C=C3)O)=O)CC4=CNC5=CC=CC=C45)=O)=O)CC6=CNC7=CC=CC=C67)=O)=O
Molecular Formula
C61H75N15O12
Molecular Weight
1210.34
References & Citations
[1]Solid-phase synthesis of neurokinin A antagonists. Comparison of the Boc and Fmoc methods
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC403788-500 1x 500 µL
CD14 (Monocyte / Macrophage Marker) (rLPSR/2408), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
